Brief: Tenax Therapeutics Granted U.S. Patent For The Subcutaneous Use Of Levosimendan

Tenax Therapeutics

12/01/2022 13:59

Jan 12 (Reuters) - Tenax Therapeutics Inc  TENX.O :
    * TENAX THERAPEUTICS GRANTED U.S. PATENT FOR THE
SUBCUTANEOUS USE
OF LEVOSIMENDAN (TNX-102)

Source text for Eikon:  ID:nGNX5F0lfy 
Further company coverage:  TENX.O 

 ((Reuters.Briefs@thomsonreuters.com;))